All Stories

  1. Morbidity and Mortality of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients Aged 70 Years and Older: A Two‐Center 10‐Year Experience
  2. The Role of Diagnostic Laparoscopy in Staging and Treatment Planning of Gastric Cancer: A 400-Patient Retrospective Cohort Study
  3. International practice patterns and perceptions of pressurised intraperitoneal aerosol chemotherapy for management of gastric cancer: A global clinician survey
  4. Intravoxel incoherent motion diffusion-weighted imaging in the staging of rectal non-mucinous adenocarcinoma
  5. Pressurized intraperitoneal aerosol chemotherapy in peritoneal carcinomatosis due to recurrent ovarian cancer
  6. Towards safer colorectal surgery worldwide: Outcomes and benchmarks from the ESCP CORREA 2022 audit
  7. Assessing data completeness in the international society for the study of pleura and peritoneum (ISSPP) PIPAC database: a multicenter evaluation from 2020–2024
  8. Real-world data on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed therapy in patients with peritoneal metastases; Third annual report from the ISSPP PIPAC database
  9. Reply to “Letter to the Editor Re: Safety and Feasibility of Nephrectomy in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis”
  10. Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Cases of Peritoneal Carcinomatosis that Require Nephrectomy
  11. The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis
  12. Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection
  13. The Role of Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in Recurrent Ovarian Peritoneal Carcinomatosis
  14. The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort Study
  15. The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study
  16. The management of goal-directed fluid therapy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  17. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives
  18. Toward a new paradigm of care: a surgical leaders’ Delphi consensus on the organizational factors of the new pancreas units (E-AHPBA PUECOF study)
  19. Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review
  20. Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus
  21. Abstract 460: Fecal microRNA and microbiome profiles in colorectal cancer patients: Are they predictor of survival and how do behave in longitudinal samples
  22. ASO Visual Abstract: The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors
  23. The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors
  24. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer
  25. Different Periampullary Types and Subtypes Leading to Different Perioperative Outcomes of Pancreatoduodenectomy: Reality and Not a Myth; An International Multicenter Cohort Study
  26. SF‐CORNER (splenic flexure colorectal cancer): an international survey of operative approaches and outcomes for cancers of the splenic flexure
  27. Can Low Anterior Resection Syndrome be Managed Medically in Coloanal Anastomosis?
  28. Colorectal cancer surgeries: Are we experiencing difficulties in implementing ERAS protocols?
  29. Variation in hospital performances after colorectal cancer surgery: A case-mix adjusted Dutch population based study
  30. Endoscopic Management of Gastro-Entero-Pancreatic Neuroendocrine Tumours: An Overview of Proposed Resection and Ablation Techniques
  31. Current Surgical and Medical Oncological Treatment Approaches in Metastatic Gastric Cancer
  32. Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection
  33. Second annual report from the ISSPP PIPAC database
  34. Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
  35. Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries
  36. Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma
  37. Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients
  38. Outcomes of elective liver surgery worldwide: a global, prospective, multicenter, cross-sectional study
  39. Learning Curves of Minimally Invasive Distal Pancreatectomy in Experienced Pancreatic Centers
  40. Stoma-free Survival After Rectal Cancer Resection With Anastomotic Leakage
  41. The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS)
  42. Oncological outcomes after pancreatoduodenectomy for pancreatic ductal adenocarcinoma in octogenarians: case-control study
  43. Comparison of proactive and conventional treatment of anastomotic leakage in rectal cancer surgery: a multicentre retrospective cohort series
  44. Performance and Safety of EUS Ablation Techniques for Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis
  45. The Effectiveness of the Serum Neutrophil-lymphocyte Ratio in the Determination of an Advanced Stage in Colorectal Cancers
  46. 77P 5-year results of cytoreductive surgery in peritoneal and retroperitoneal sarcomatosis
  47. ASO Visual Abstract: Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer—An International Retrospective Cohort Study
  48. Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study
  49. Incidence and risk factors for anastomotic bile leakage in hepatic resection with bilioenteric reconstruction – A international multicenter study
  50. Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study
  51. HPB P03 Oncological outcomes are comparable between octogenarians and younger patients after pancreatoduodenectomy for pancreatic ductal adenocarcinoma
  52. Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance
  53. Benchmarking of robotic and laparoscopic spleen-preserving distal pancreatectomy by using two different methods
  54. Is There a Role for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis Due to Uterine Cancer?
  55. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation
  56. Did the ERAS Protocol Improve Our Results in Locally Advanced Gastric Cancer Surgery?
  57. Magnetic Nanoparticle-Based Electrochemical Sensing Platform Using Ferrocene-Labelled Peptide Nucleic Acid for the Early Diagnosis of Colorectal Cancer
  58. International expert opinion on optimal treatment of anastomotic leakage after rectal cancer resection: a case-vignette study
  59. Long-Term Oncological Outcomes After Colorectal Anastomotic Leakage
  60. Benchmarking of minimally invasive distal pancreatectomy with splenectomy: European multicentre study
  61. Endoscopic vacuum-assisted surgical closure (EVASC) of anastomotic defects after low anterior resection for rectal cancer; lessons learned
  62. Major Surgical Resections in Abdominopelvic Sarcomas: Clinical Features and Results of 38 patients: A Tertiary-Center Experience
  63. Short-term outcomes after pancreatoduodenectomy in octogenarians: multicentre case–control study
  64. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin
  65. Evidence Map of Pancreatic Surgery–A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS)
  66. Trends in risk factors of anastomotic leakage after colorectal cancer surgery (2011–2019): A Dutch population‐based study
  67. Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic Conundrum
  68. Postpancreatectomy Acute Pancreatitis (PPAP)
  69. Combined Resections for Synchronous Colorectal Liver Metastases: Are Two Teams Better than One?
  70. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis
  71. Perihilar Cholangiocarcinoma – Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers
  72. 5 year study results of simultaneous pancreas resection during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  73. Results of sımultaneous pancreas resectıon after neoadjuvant chemotherapy in local advenced gastric cancers
  74. Short-term Outcomes After Spleen-preserving Minimally Invasive Distal Pancreatectomy With or Without Preservation of Splenic Vessels
  75. Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study
  76. Solid Pseudopapillary Neoplasms of the Pancreas: a Single-Center Experience and Review of the Literature
  77. Is Cytoreductive Surgery Possible in Cervical Cancer Peritoneal Carcinomatosis?
  78. The Economic Burden of Postoperative Complications Predicted by the Comprehensive Complication Index®in Patients Undergoing Elective Major Hepatopancreaticobiliary Surgery for Malignancy – A Prospective Cost Analysis
  79. Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience
  80. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment
  81. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma
  82. Hepatopancreatoduodenectomy –a controversial treatment for bile duct and gallbladder cancer from a European perspective
  83. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
  84. Clinical features and surgical outcomes of major urological interventions during cytoreductive surgery and hyperthermic intraperitoneal chemotheraphy
  85. Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence
  86. The Role of Magnetic Resonance Imaging in the Differential Diagnosis of Giant Rectal and Perirectal Masses
  87. Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
  88. Safety of coloanal/ileoanal anastomosis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: results of 20 consecutive patients
  89. Decellularized Human Gut as a Natural 3D Platform for Research in Intestinal Fibrosis
  90. Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms
  91. Preoperative Ca125 Value Predicts Glisson Capsule Involvement in Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  92. Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma
  93. Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis
  94. Evaluation of Enhanced Recovery After Following a Surgical Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
  95. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
  96. Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients
  97. Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and Liver
  98. Impact of postoperative intravenous fluid administration on complications following elective hepato-pancreato-biliary surgery
  99. Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Mean Platelet Volume for Detection of Resectable Pancreas Cancer
  100. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients
  101. Short-term Quality of Life after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  102. The Southampton Consensus Guidelines for Laparoscopic Liver Surgery
  103. Comparison of platelet rich plasma versus fibrin glue on colonic anastomoses in rats
  104. Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study
  105. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study
  106. Effects of nivolumab in peritoneal carcinamatosis of malign melanoma in mouse model
  107. Gallbladder polypoid lesions >15 mm as indicators of T1b gallbladder cancer risk
  108. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro
  109. Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial
  110. Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs)
  111. İntramukozal yerleşimli taşlı yüzük hücreli mide kanserinde lenfatik metastaz
  112. Should we consider pancreaticogastrostomy the best method of reconstruction after pancreaticoduodenectomy?
  113. Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy: An Up-to-date Meta-Analysis
  114. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
  115. Major Hepatectomy for Colorectal Metastases in the Elderly: A Tertiary Center Experience
  116. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
  117. Obesity and pancreatic cancer
  118. Portal Vein Resection in Borderline Resectable Pancreatic Cancer: A United Kingdom Multicenter Study
  119. Resection versus other treatments for locally advanced pancreatic cancer
  120. Rare presentation of self-resolving multifocal inflammatory pseudo-tumour of liver
  121. Systematic review of novel ablative methods in locally advanced pancreatic cancer
  122. Development of a Composite Endpoint for Randomized Controlled Trials in Pancreaticoduodenectomy
  123. Miniports versus standard ports for laparoscopic cholecystectomy
  124. Early versus delayed laparoscopic cholecystectomy for uncomplicated biliary colic
  125. Somatostatin analogues for pancreatic surgery
  126. Is there a role for arterial reconstruction in surgery for pancreatic cancer?
  127. Robot assistant versus human or another robot assistant in patients undergoing laparoscopic cholecystectomy
  128. Remote preconditioning improves hepatic oxygenation after ischaemia reperfusion injury
  129. Risk factors associated with early hepatic artery thrombosis after orthotopic liver transplantation - univariable
and multivariable analysis
  130. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review
  131. Miniport versus standard ports for laparoscopic cholecystectomy
  132. Somatostatin analogues for pancreatic surgery
  133. Small for size syndrome following living donor and split liver transplantation
  134. Robot assistant for laparoscopic cholecystectomy
  135. Long-Term Survival and Disease Recurrence Following Portal Vein Embolisation Prior to Major Hepatectomy for Colorectal Metastases
  136. Early versus delayed laparoscopic cholecystectomy for biliary colic